Sana Biotechnology, Inc. (SANA)

NASDAQ: SANA · Real-Time Price · USD

3.550

-0.120 (-3.27%)

At close: Aug 14, 2026, 4:00 PM EDT

3.580

+0.030 (0.85%)

After-hours: Aug 14, 2026, 7:34 PM EDT

Sana Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	57.07	71.87	127.57	133.52	176.77	253.03
Short-Term Investments	103.42	66.51	24.93	71.68	247.2	297.97
Cash & Short-Term Investments	160.49	138.38	152.5	205.2	423.96	551
Cash Growth	120.84%	-9.26%	-25.68%	-51.60%	-23.05%	45.66%
Prepaid Expenses	5.94	6.1	4.48	4.49	14.37	7.11
Restricted Cash	4.2	4.2	3.83	3.83	6.1	-
Total Current Assets	170.63	148.68	160.81	213.52	444.44	558.1
Property, Plant & Equipment	60.52	65.22	135.27	145.59	159.4	161.78
Long-Term Investments	-	-	-	-	10.05	195.88
Goodwill	140.63	140.63	140.63	140.63	140.63	140.63
Other Intangible Assets	59.2	59.2	59.2	59.2	59.2	59.2
Other Long-Term Assets	0.55	3.17	5.12	6.37	9.01	13.82
Total Assets	431.52	416.89	501.02	565.3	822.72	1,129

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.36	1.67	5.21	4.11	2.86	2.22
Accrued Expenses	16.67	21.52	27.69	37.98	39.12	28.91
Current Portion of Leases	14.91	15.34	12.53	13.2	12.39	9.16
Other Current Liabilities	90.81	40.2	-	9.2	57.14	58.95
Total Current Liabilities	123.75	78.73	45.43	64.49	111.5	99.24
Long-Term Leases	66.03	70.92	81.66	90.9	95.86	101.78
Other Long-Term Liabilities	87.17	106.36	123.42	122.41	116.04	199.89
Total Liabilities	276.95	256.01	250.52	277.79	323.41	400.91

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.03	0.03	0.02	0.02	0.02	0.02
Additional Paid-In Capital	2,114	2,010	1,855	1,626	1,558	1,515
Retained Earnings	-1,960	-1,849	-1,605	-1,338	-1,055	-785.36
Comprehensive Income & Other	-0.07	0.03	0.01	-0.06	-4.33	-1.37
Total Common Equity	154.57	160.88	250.5	287.51	499.32	728.5
Shareholders' Equity	154.57	160.88	250.5	287.51	499.32	728.5
Total Liabilities & Equity	431.52	416.89	501.02	565.3	822.72	1,129

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	80.94	86.26	94.2	104.1	108.25	110.94
Net Cash (Debt)	79.55	52.12	58.3	101.1	325.76	635.93
Net Cash Growth	-	-10.60%	-42.33%	-68.97%	-48.77%	86.99%
Net Cash Per Share	0.29	0.21	0.25	0.52	1.73	3.82
Filing Date Shares Outstanding	299.36	266.87	225.02	220.45	191.35	185.18
Total Common Shares Outstanding	299.31	266.73	223.92	197.86	191.02	184.93
Working Capital	46.88	69.95	115.38	149.03	332.93	458.87
Book Value Per Share	0.52	0.60	1.12	1.45	2.61	3.94
Tangible Book Value	-45.25	-38.94	50.68	87.68	299.49	528.68
Tangible Book Value Per Share	-0.15	-0.15	0.23	0.44	1.57	2.86
Machinery	45.49	42.6	57.79	54.77	64.76	49
Construction In Progress	-	-	40.34	26.33	1.71	1.39
Leasehold Improvements	39.06	39.06	33.34	31.36	34.43	33.85

SEC Filings: 10-K · 10-Q